Also known as Lexiscan
Regadenoson (INN, code named CVT-3146) is an A2A adenosine receptor agonist that is a coronary vasodilator. It produces maximal hyperemia quickly and maintains it for an optimal duration that is practical for radionuclide myocardial perfusion imaging.Source: Wikipedia
Patients are most commonly prescribed regadenoson to treat sharp chest pain, coronary atherosclerosis, shortness of breath, and chest tightness.
Patients taking regadenoson most commonly experience side effects like headache, arrhythmia, and atrial fibrillation.